Learn more

PHARMALEADS

Overview
  • Total Patents
    110
  • GoodIP Patent Rank
    28,945
  • Filing trend
    ⇧ 1200.0%
About

PHARMALEADS has a total of 110 patent applications. It increased the IP activity by 1200.0%. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are GUANGDONG ZONK DRUG R & D LTD, ALEXION PHARMA INT OPERATIONS UNLIMITED COMPANY and SHORR ROBERT.

Patent filings per year

Chart showing PHARMALEADSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Poras Herve 47
#2 Fournie-Zaluski Marie-Claude 42
#3 Roques Bernard 42
#4 Poras Hervé 27
#5 Wurm Michel 27
#6 Fournie Zaluski Marie Claude 15
#7 Roques Bernard Pierre 15
#8 Reaux-Le Goazigo Annabelle 15
#9 Ouimet Tanja 12
#10 Melik Parsadaniantz Stephane 11

Latest patents

Publication Filing date Title
FR3098217A1 N-Formylhydroxylamines as mixed inhibitors of aminopeptidase N (APN) and neprilysin (NEP)
TW201840321A Aminophosphinic derivatives for preventing and treating eye inflammation
FR3077201A1 AMINO ACID DERIVATIVES CONTAINING A DISULFANYL GROUP IN THE FORM OF A NEP AND APN INHIBITOR FOR THE PREVENTION AND TREATMENT OF PAIN RELATING TO TWIN Nerve
FR3063635A1 AMINOPHOSPHINIC DERIVATIVES FOR THE PREVENTION AND TREATMENT OF OCULAR INFLAMMATION
TW201718479A Industrial process for the preparation of (5s,10s)-10-benzyl-16-methyl-11,14,18-trioxo-15,17,19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium (e)-3-carboxyacrylate salt
FR3044227A1 AMINOPHOSPHINE DERIVATIVES FOR THE PREVENTION AND TREATMENT OF EYE PAIN
WO2014064162A1 Neprilysin inhibitors
CN104797557A Mixed inhibitors of aminopeptidase n and of neprilysine
CA2813219A1 Novel substrates the fluorescence of which is suppressed, preparation thereof, and use thereof for identifying, detecting, and assaying legionella pneumophilia
EP2740736A1 Aminophosphinic derivatives suitable for use in the treatment of pain
NZ588955A Novel amino acid derivatives including a disulfide (disulphide), method for preparing same, and therapeutic use thereof
WO2008003773A1 Method for detecting interactions using the fluorescence reporter pyrenylalanine
CN101316833A Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors
AU2006307938A1 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors
EP1743034A2 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof
CN1969046A Peptide substrates recognisable by a botulinum toxin A, BoNT/A and the use thereof